Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Contemporary clinical risk stratification schemata for predicting stroke and thromboembolism (TE) in patients with atrial fibrillation (AF) are largely derived from risk factors identified from trial cohorts. Thus, many potential risk factors have not been included. METHODS: We refined the 2006 Birmingham/National Institute for Health and Clinical Excellence (NICE) stroke risk stratification schema into a risk factor-based approach by reclassifying and/or incorporating additional new risk factors where relevant. This schema was then compared with existing stroke risk stratification schema in a real-world cohort of patients with AF (n = 1,084) from the Euro Heart Survey for AF. RESULTS: Risk categorization differed widely between the different schemes compared. Patients classified as high risk ranged from 10.2% with the Framingham schema to 75.7% with the Birmingham 2009 schema. The classic CHADS(2) (Congestive heart failure, Hypertension, Age > 75, Diabetes, prior Stroke/transient ischemic attack) schema categorized the largest proportion (61.9%) into the intermediate-risk strata, whereas the Birmingham 2009 schema classified 15.1% into this category. The Birmingham 2009 schema classified only 9.2% as low risk, whereas the Framingham scheme categorized 48.3% as low risk. Calculated C-statistics suggested modest predictive value of all schema for TE. The Birmingham 2009 schema fared marginally better (C-statistic, 0.606) than CHADS(2). However, those classified as low risk by the Birmingham 2009 and NICE schema were truly low risk with no TE events recorded, whereas TE events occurred in 1.4% of low-risk CHADS(2) subjects. When expressed as a scoring system, the Birmingham 2009 schema (CHA(2)DS(2)-VASc acronym) showed an increase in TE rate with increasing scores (P value for trend = .003). CONCLUSIONS: Our novel, simple stroke risk stratification schema, based on a risk factor approach, provides some improvement in predictive value for TE over the CHADS(2) schema, with low event rates in low-risk subjects and the classification of only a small proportion of subjects into the intermediate-risk category. This schema could improve our approach to stroke risk stratification in patients with AF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, diabetes may not be a significant risk factor for stroke in the elderly.620”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [620]
Experimental — accuracy not yet measuredIn the citing paper
“while patients with stroke risk factors (i.e.CHA 2 DS 2 -VASc score of 1 or more for men, and 2 or more for women) are likely to benefit from OAC.”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [368]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793
(1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420130036007 · Cited by 2,071
Mant, J., Hobbs, F. R., Fletcher, K., Roalfe, A., Fitzmaurice, D., Lip, G. Y., & Murray, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61233-1 · Cited by 1,556
Self-citationBelch, J., MacCuish, A., Campbell, I., Cobbe, S., Taylor, R., Prescott, R., Lee, R., Bancroft, J., MacEwan, S., Shepherd, J., et al. (2008) · BMJ · doi:10.1136/bmj.a1840 · Cited by 977
Connolly, S. J., Pogue, J., Eikelboom, J., Flaker, G., Commerford, P., Franzosi, M. G., Healey, J. S., & Yusuf, S. (2008) · Circulation · doi:10.1161/circulationaha.107.750000 · Cited by 870
Wang, T. J., Massaro, J. M., Levy, D., Vasan, R. S., Wolf, P. A., D'Agostino, R. B., Larson, M. G., Kannel, W. B., & Benjamin, E. J. (2003) · JAMA · doi:10.1001/jama.290.8.1049 · Cited by 780
Antithrombotic Therapy in Atrial Fibrillation
Singer, D. E., Albers, G. W., Dalen, J. E., Fang, M. C., Go, A. S., Halperin, J. L., Lip, G. Y. H., & Manning, W. J. (2008) · Chest · doi:10.1378/chest.08-0678 · Cited by 751
Self-citationGage, B. F., van Walraven, C., Pearce, L., Hart, R. G., Koudstaal, P. J., Boode, B. S. P., & Petersen, P. (2004) · Circulation · doi:10.1161/01.cir.0000145172.55640.93 · Cited by 749
Cited by
Items 101–200 of 1,020
Lane, D. A., & Lip, G. Y. H. (2012) · Circulation · doi:10.1161/circulationaha.111.060061 · Cited by 388
Self-citationArtificial intelligence for proteomics and biomarker discovery
Mann, M., Kumar, C., Zeng, W.-F., & Strauss, M. T. (2021) · Cell Systems · doi:10.1016/j.cels.2021.06.006 · Cited by 385
Hankey, G. J. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70255-2 · Cited by 384
The Global Burden of Atrial Fibrillation and Stroke
Lip, G. Y. H., Brechin, C. M., & Lane, D. A. (2012) · Chest · doi:10.1378/chest.11-2888 · Cited by 379
Self-citationUpdates in Chronic Subdural Hematoma: Epidemiology, Etiology, Pathogenesis, Treatment, and Outcome
Feghali, J., Yang, W., & Huang, J. (2020) · World Neurosurgery · doi:10.1016/j.wneu.2020.06.140 · Cited by 379
Halvorsen, S., Atar, D., Yang, H., De Caterina, R., Erol, C., Garcia, D., Granger, C. B., Hanna, M., Held, C., Husted, S., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu046 · Cited by 370
Gallagher, A., Setakis, E., Plumb, J., Clemens, A., & van Staa, T.-P. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-05-0353 · Cited by 359
Perioperative atrial fibrillation and the long-term risk of ischemic stroke
Gialdini, G., Nearing, K., Bhave, P. D., Bonuccelli, U., Iadecola, C., Healey, J. S., & Kamel, H. (2014) · JAMA · doi:10.1001/jama.2014.9143 · Cited by 355
Lubitz, S. A., Faranesh, A. Z., Selvaggi, C., Atlas, S. J., McManus, D. D., Singer, D. E., Pagoto, S., McConnell, M. V., Pantelopoulos, A., & Foulkes, A. S. (2022) · Circulation · doi:10.1161/circulationaha.122.060291 · Cited by 355
Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women
Cho, L., Davis, M., Elgendy, I., Epps, K., Lindley, K. J., Mehta, P. K., Michos, E. D., Minissian, M., Pepine, C., Vaccarino, V., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.060 · Cited by 347
Donal, E., Lip, G. Y. H., Galderisi, M., Goette, A., Shah, D., Marwan, M., Lederlin, M., Mondillo, S., Edvardsen, T., Sitges, M., et al. (2016) · European Heart Journal – Cardiovascular Imaging · doi:10.1093/ehjci/jev354 · Cited by 341
Self-citationLip, G. Y., Tse, H. F., & Lane, D. A. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61514-6 · Cited by 338
Self-citationRodés-Cabau, J., Masson, J.-B., Welsh, R. C., Garcia del Blanco, B., Pelletier, M., Webb, J. G., Al-Qoofi, F., Généreux, P., Maluenda, G., Thoenes, M., et al. (2017) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2017.04.014 · Cited by 331
Ouwerkerk, W., Voors, A. A., & Zwinderman, A. H. (2014) · JACC: Heart Failure · doi:10.1016/j.jchf.2014.04.006 · Cited by 328
Daoud, E. G., Glotzer, T. V., Wyse, D. G., Ezekowitz, M. D., Hilker, C., Koehler, J., & Ziegler, P. D. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.04.022 · Cited by 326
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion
Meier, B., Blaauw, Y., Khattab, A. A., Lewalter, T., Sievert, H., Tondo, C., Glikson, M., ESC Scientific Document Group, Lip, G. Y. H., Lopez-Minguez, J., et al. (2014) · EP Europace · doi:10.1093/europace/euu174 · Cited by 324
Self-citationECG-Based Deep Learning and Clinical Risk Factors to Predict Atrial Fibrillation
Khurshid, S., Friedman, S., Reeder, C., Di Achille, P., Diamant, N., Singh, P., Harrington, L. X., Wang, X., Al-Alusi, M. A., Sarma, G., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.057480 · Cited by 322
Lip, G. Y. H., Laroche, C., Dan, G.-A., Santini, M., Kalarus, Z., Rasmussen, L. H., Oliveira, M. M., Mairesse, G., Crijns, H. J. G. M., Simantirakis, E., et al. (2014) · EP Europace · doi:10.1093/europace/eut373 · Cited by 322
Self-citationStroke Prevention in Atrial Fibrillation: A Systematic Review
Lip, G. Y. H., & Lane, D. A. (2015) · JAMA · doi:10.1001/jama.2015.4369 · Cited by 322
Self-citationHigh Prevalence of Atrial Fibrillation Among Patients With Ischemic Stroke
Friberg, L., Rosenqvist, M., Lindgren, A., Terént, A., Norrving, B., & Asplund, K. (2014) · Stroke · doi:10.1161/strokeaha.114.006070 · Cited by 322
Hernández-Madrid, A., Paul, T., Abrams, D., Aziz, P. F., Blom, N. A., Chen, J., Chessa, M., Combes, N., Dagres, N., Diller, G., et al. (2018) · EP Europace · doi:10.1093/europace/eux380 · Cited by 317
Vanassche, T., Lauw, M. N., Eikelboom, J. W., Healey, J. S., Hart, R. G., Alings, M., Avezum, A., Diaz, R., Hohnloser, S. H., Lewis, B. S., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu307 · Cited by 313
Raghunath, S., Pfeifer, J. M., Ulloa-Cerna, A. E., Nemani, A., Carbonati, T., Jing, L., vanMaanen, D. P., Hartzel, D. N., Ruhl, J. A., Lagerman, B. F., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.047829 · Cited by 312
Graham, D. J., Reichman, M. E., Wernecke, M., Hsueh, Y.-H., Izem, R., Southworth, M. R., Wei, Y., Liao, J., Goulding, M. R., Mott, K., et al. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.5954 · Cited by 312
Wallentin, L., Hijazi, Z., Andersson, U., Alexander, J. H., De Caterina, R., Hanna, M., Horowitz, J. D., Hylek, E. M., Lopes, R. D., Åsberg, S., et al. (2014) · Circulation · doi:10.1161/circulationaha.114.011204 · Cited by 310
Faust, O., Shenfield, A., Kareem, M., San, T. R., Fujita, H., & Acharya, U. R. (2018) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2018.07.001 · Cited by 309
Zimmerman, D., Sood, M. M., Rigatto, C., Holden, R. M., Hiremath, S., & Clase, C. M. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs416 · Cited by 308
Banerjee, A., Lane, D. A., Torp-Pedersen, C., & Lip, G. Y. H. (2012) · Thrombosis and Haemostasis · doi:10.1160/th11-11-0784 · Cited by 301
Self-citationBiomarkers in atrial fibrillation: a clinical review
Hijazi, Z., Oldgren, J., Siegbahn, A., Granger, C. B., & Wallentin, L. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht024 · Cited by 298
Cardiovascular Research Using the Korean National Health Information Database
Choi, E.-K. (2020) · Korean Circulation Journal · doi:10.4070/kcj.2020.0171 · Cited by 298
Linde, C., Bongiorni, M. G., Birgersdotter-Green, U., Curtis, A. B., Deisenhofer, I., Furokawa, T., Gillis, A. M., Haugaa, K. H., Lip, G. Y. H., Van Gelder, I., et al. (2018) · EP Europace · doi:10.1093/europace/euy067 · Cited by 296
Self-citationKralev, S., Schneider, K., Lang, S., Süselbeck, T., & Borggrefe, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024964 · Cited by 295
Hsu, J. C., Maddox, T. M., Kennedy, K. F., Katz, D. F., Marzec, L. N., Lubitz, S. A., Gehi, A. K., Turakhia, M. P., & Marcus, G. M. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2015.0374 · Cited by 294
Cairns, J. A., Connolly, S., McMurtry, S., Stephenson, M., & Talajic, M. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2010.11.007 · Cited by 292
Kato, E. T., Giugliano, R. P., Ruff, C. T., Koretsune, Y., Yamashita, T., Kiss, R. G., Nordio, F., Murphy, S. A., Kimura, T., Jin, J., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003432 · Cited by 288
Stroke prevention in atrial fibrillation: An Asian perspective
Wang, K.-L., Lip, G. Y. H., & Chiang, C.-E. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-11-0948 · Cited by 287
Self-citationGo, A. S., Reynolds, K., Yang, J., Gupta, N., Lenane, J., Sung, S. H., Harrison, T. N., Liu, T. I., & Solomon, M. D. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.1176 · Cited by 286
Bonde, A. N., Lip, G. Y. H., Kamper, A.-L., Hansen, P. R., Lamberts, M., Hommel, K., Hansen, M. L., Gislason, G. H., Torp-Pedersen, C., & Olesen, J. B. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.051 · Cited by 285
Self-citationStroke Risk as a Function of Atrial Fibrillation Duration and CHA 2 DS 2 -VASc Score
Kaplan, R. M., Koehler, J., Ziegler, P. D., Sarkar, S., Zweibel, S., & Passman, R. S. (2019) · Circulation · doi:10.1161/circulationaha.119.041303 · Cited by 284
Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care
Lane, D. A., Skjøth, F., Lip, G. Y. H., Larsen, T. B., & Kotecha, D. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005155 · Cited by 283
Self-citationPaciaroni, M., Agnelli, G., Falocci, N., Caso, V., Becattini, C., Marcheselli, S., Rueckert, C., Pezzini, A., Poli, L., Padovani, A., et al. (2015) · Stroke · doi:10.1161/strokeaha.115.008891 · Cited by 282
Fauchier, L., Hylek, E., Knight, E., Lane, D., Levi, M., Marin, F., Palareti, G., Collet, J.-P., Rubboli, A., Poli, D., et al. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-10-0690 · Cited by 280
Self-citationLuik, A., Radzewitz, A., Kieser, M., Walter, M., Bramlage, P., Hörmann, P., Schmidt, K., Horn, N., Brinkmeier-Theofanopoulou, M., Kunzmann, K., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.016871 · Cited by 275
Moving the Tipping Point: The Decision to Anticoagulate Patients With Atrial Fibrillation
Eckman, M. H., Singer, D. E., Rosand, J., & Greenberg, S. M. (2011) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.958108 · Cited by 275
Piccini, J. P., Simon, D. N., Steinberg, B. A., Thomas, L., Allen, L. A., Fonarow, G. C., Gersh, B., Hylek, E., Kowey, P. R., Reiffel, J. A., et al. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.0529 · Cited by 273
VAN STAA, T. P., SETAKIS, E., DI TANNA, G. L., LANE, D. A., & LIP, G. Y. H. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04085.x · Cited by 272
Self-citationFurie, K. L., Goldstein, L. B., Albers, G. W., Khatri, P., Neyens, R., Turakhia, M. P., Turan, T. N., & Wood, K. A. (2012) · Stroke · doi:10.1161/str.0b013e318266722a · Cited by 270
Friberg, L., Benson, L., Rosenqvist, M., & Lip, G. Y. H. (2012) · BMJ · doi:10.1136/bmj.e3522 · Cited by 268
Self-citationBrown, J. R., Moslehi, J., O’Brien, S., Ghia, P., Hillmen, P., Cymbalista, F., Shanafelt, T. D., Fraser, G., Rule, S., Kipps, T. J., et al. (2017) · Haematologica · doi:10.3324/haematol.2017.171041 · Cited by 267
New Oral Anticoagulants in Elderly Adults: Evidence from a Meta‐Analysis of Randomized Trials
Sardar, P., Chatterjee, S., Chaudhari, S., & Lip, G. Y. H. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12799 · Cited by 267
Self-citationPiccini, J. P., Stevens, S. R., Lokhnygina, Y., Patel, M. R., Halperin, J. L., Singer, D. E., Hankey, G. J., Hacke, W., Becker, R. C., Nessel, C. C., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.025 · Cited by 266
Nielsen, P. B., Larsen, T. B., Skjøth, F., Gorst-Rasmussen, A., Rasmussen, L. H., & Lip, G. Y. H. (2015) · Circulation · doi:10.1161/circulationaha.115.015735 · Cited by 265
Self-citationGuidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2013):– Digest Version –
JCSJointWorkingGroup (2014) · Circulation · Cited by 262
Gaita, F., Corsinovi, L., Anselmino, M., Raimondo, C., Pianelli, M., Toso, E., Bergamasco, L., Boffano, C., Valentini, M. C., Cesarani, F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.074 · Cited by 261
Chao, T.-F., Liu, C.-J., Wang, K.-L., Lin, Y.-J., Chang, S.-L., Lo, L.-W., Hu, Y.-F., Tuan, T.-C., Chen, T.-J., Lip, G. Y. H., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.11.046 · Cited by 258
Self-citationLong-term Outcomes Following Development of New-Onset Atrial Fibrillation During Sepsis
Walkey, A. J., Hammill, B. G., Curtis, L. H., & Benjamin, E. J. (2014) · Chest · doi:10.1378/chest.14-0003 · Cited by 256
Atrial fibrillation prevalence revisited
Friberg, L., & Bergfeldt, L. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12114 · Cited by 255
Castaño, A., Drachman, B. M., Judge, D., & Maurer, M. S. (2015) · Heart Failure Reviews · doi:10.1007/s10741-014-9462-7 · Cited by 254
Nielsen, P. B., Skjøth, F., Overvad, T. F., Larsen, T. B., & Lip, G. Y. H. (2018) · Circulation · doi:10.1161/circulationaha.117.029081 · Cited by 253
Self-citationHypertension and Atrial Fibrillation: Doubts and Certainties From Basic and Clinical Studies
Verdecchia, P., Angeli, F., & Reboldi, G. (2018) · Circulation Research · doi:10.1161/circresaha.117.311402 · Cited by 252
Chung, M. K., Refaat, M., Shen, W.-K., Kutyifa, V., Cha, Y.-M., Di Biase, L., Baranchuk, A., Lampert, R., Natale, A., Fisher, J., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.02.025 · Cited by 252
Raval, A. N., Cigarroa, J. E., Chung, M. K., Diaz-Sandoval, L. J., Diercks, D., Piccini, J. P., Jung, H. S., Washam, J. B., Welch, B. G., Zazulia, A. R., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000477 · Cited by 251
Mairesse, G. H., Moran, P., Van Gelder, I. C., Elsner, C., Rosenqvist, M., Mant, J., Banerjee, A., Gorenek, B., Brachmann, J., Varma, N., et al. (2017) · EP Europace · doi:10.1093/europace/eux177 · Cited by 250
Self-citationGorenek, B., Bax, J., Boriani, G., Chen, S.-A., Dagres, N., Glotzer, T. V., Healey, J. S., Israel, C. W., Kudaiberdieva, G., Levin, L.-Å., et al. (2017) · EP Europace · doi:10.1093/europace/eux163 · Cited by 247
Self-citationGoldberger, J. J., Arora, R., Green, D., Greenland, P., Lee, D. C., Lloyd-Jones, D. M., Markl, M., Ng, J., & Shah, S. J. (2015) · Circulation · doi:10.1161/circulationaha.115.016795 · Cited by 243
Sex Differences in Stroke Risk Among Older Patients With Recently Diagnosed Atrial Fibrillation
Jackevicius, C. A. (2012) · JAMA · doi:10.1001/jama.2012.3490 · Cited by 241
Chan, P., Wong, C., Poh, Y. C., Pun, L., Leung, W. W., Wong, Y., Wong, M. M., Poh, M., Chu, D. W., & Siu, C. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003428 · Cited by 240
Trends in the prescription of novel oral anticoagulants in UK primary care
Loo, S. Y., Dell'Aniello, S., Huiart, L., & Renoux, C. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13299 · Cited by 240
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
Camm, A. J., Accetta, G., Ambrosio, G., Atar, D., Bassand, J.-P., Berge, E., Cools, F., Fitzmaurice, D. A., Goldhaber, S. Z., Goto, S., et al. (2017) · Heart · doi:10.1136/heartjnl-2016-309832 · Cited by 240
Postoperative Arrhythmias after Cardiac Surgery: Incidence, Risk Factors, and Therapeutic Management
Peretto, G., Durante, A., Limite, L. R., & Cianflone, D. (2014) · Cardiology Research and Practice · doi:10.1155/2014/615987 · Cited by 239
Lip, G. Y. H., Fauchier, L., Freedman, S. B., Van Gelder, I., Natale, A., Gianni, C., Nattel, S., Potpara, T., Rienstra, M., Tse, H.-F., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.16 · Cited by 238
Self-citationLip, G. Y. H., Laroche, C., Ioachim, P. M., Rasmussen, L. H., Vitali-Serdoz, L., Petrescu, L., Darabantiu, D., Crijns, H. J. G. M., Kirchhof, P., Vardas, P., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu374 · Cited by 237
Self-citationTiming of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation
Seiffge, D. J., Werring, D. J., Paciaroni, M., Dawson, J., Warach, S., Milling, T. J., Engelter, S. T., Fischer, U., & Norrving, B. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30356-9 · Cited by 237
Noseworthy, P. A., Yao, X., Abraham, N. S., Sangaralingham, L. R., McBane, R. D., & Shah, N. D. (2016) · Chest · doi:10.1016/j.chest.2016.07.013 · Cited by 236
Akao, M., Chun, Y.-H., Wada, H., Esato, M., Hashimoto, T., Abe, M., Hasegawa, K., Tsuji, H., & Furuke, K. (2013) · Journal of Cardiology · doi:10.1016/j.jjcc.2012.12.002 · Cited by 236
Andrade, J. G., Verma, A., Mitchell, L. B., Parkash, R., Leblanc, K., Atzema, C., Healey, J. S., Bell, A., Cairns, J., Connolly, S., et al. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.08.026 · Cited by 233
Age as a Risk Factor for Stroke in Atrial Fibrillation Patients
Marinigh, R., Lip, G. Y. H., Fiotti, N., Giansante, C., & Lane, D. A. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.028 · Cited by 232
Self-citationN-Terminal Pro–B-Type Natriuretic Peptide for Risk Assessment in Patients With Atrial Fibrillation
Hijazi, Z., Wallentin, L., Siegbahn, A., Andersson, U., Christersson, C., Ezekowitz, J., Gersh, B. J., Hanna, M., Hohnloser, S., Horowitz, J., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.082 · Cited by 231
Healey, J. S., Brueckmann, M., Eikelboom, J. W., Ezekowitz, M. D., Fraessdorf, M., Noack, H., Oldgren, J., Reilly, P., Spyropoulos, A. C., Wallentin, L., et al. (2015) · Thrombosis and Haemostasis · doi:10.1160/th14-04-0305 · Cited by 231
Borre, E., Goode, A., Raitz, G., Shah, B., Lowenstern, A., Chatterjee, R., Sharan, L., Allen LaPointe, N., Yapa, R., Davis, J., et al. (2018) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1675400 · Cited by 229
Ischemic Stroke despite Oral Anticoagulant Therapy in Patients with Atrial Fibrillation
Seiffge, D. J., De Marchis, G. M., Koga, M., Paciaroni, M., Wilson, D., Cappellari, M., Macha, M., Tsivgoulis, G., Ambler, G., Arihiro, S., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25700 · Cited by 227
2020 Clinical guidelines for Atrial fibrillation and atrial flutter
Arakelyan, M. G., Bockeria, L. A., Vasilieva, E. Y., Golitsyn, S. P., Golukhova, E. Z., Gorev, M. V., Davtyan, K. V., Drapkina, O. M., Kropacheva, E. S., Kuchinskaya, E. A., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4594 · Cited by 225
Kornej, J., Hindricks, G., Shoemaker, M. B., Husser, D., Arya, A., Sommer, P., Rolf, S., Saavedra, P., Kanagasundram, A., Patrick Whalen, S., et al. (2015) · Clinical Research in Cardiology · doi:10.1007/s00392-015-0856-x · Cited by 224
Xian, Y., O’Brien, E. C., Liang, L., Xu, H., Schwamm, L. H., Fonarow, G. C., Bhatt, D. L., Smith, E. E., Olson, D. M., Maisch, L., et al. (2017) · JAMA · doi:10.1001/jama.2017.1371 · Cited by 224
Lip, G. Y. H., Andreotti, F., Fauchier, L., Huber, K., Hylek, E., Knight, E., Lane, D. A., Levi, M., Marin, F., Palareti, G., et al. (2011) · Europace · doi:10.1093/europace/eur126 · Cited by 223
Self-citationOral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study
Chao, T.-F., Liu, C.-J., Lin, Y.-J., Chang, S.-L., Lo, L.-W., Hu, Y.-F., Tuan, T.-C., Liao, J.-N., Chung, F.-P., Chen, T.-J., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.031658 · Cited by 223
Self-citationCaprio, F. Z., & Sorond, F. A. (2019) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.10.001 · Cited by 219
Lip, G. Y. H., Coca, A., Kahan, T., Boriani, G., Manolis, A. S., Olsen, M. H., Oto, A., Potpara, T. S., Steffel, J., Marín, F., et al. (2017) · EP Europace · doi:10.1093/europace/eux091 · Cited by 219
Self-citationKhurram, I. M., Dewire, J., Mager, M., Maqbool, F., Zimmerman, S. L., Zipunnikov, V., Beinart, R., E. Marine, J., Spragg, D. D., Berger, R. D., et al. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.09.065 · Cited by 219
Piccini, J. P., Hammill, B. G., Sinner, M. F., Hernandez, A. F., Walkey, A. J., Benjamin, E. J., Curtis, L. H., & Heckbert, S. R. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht483 · Cited by 214
Epidemiology and Mechanisms of Uremia-Related Cardiovascular Disease
Tonelli, M., Karumanchi, S. A., & Thadhani, R. (2016) · Circulation · doi:10.1161/circulationaha.115.018713 · Cited by 213
Early Safety and Efficacy of Percutaneous Left Atrial Appendage Suture Ligation
Price, M. J., Gibson, D. N., Yakubov, S. J., Schultz, J. C., Di Biase, L., Natale, A., Burkhardt, J. D., Pershad, A., Byrne, T. J., Gidney, B., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.057 · Cited by 211
Stroke in women — from evidence to inequalities
the Women Initiative for Stroke in Europe (WISE) group, Cordonnier, C., Sprigg, N., Sandset, E. C., Pavlovic, A., Sunnerhagen, K. S., Caso, V., & Christensen, H. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.95 · Cited by 147
Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48
Gupta, D. K., Shah, A. M., Giugliano, R. P., Ruff, C. T., Antman, E. M., Grip, L. T., Deenadayalu, N., Hoffman, E., Patel, I., Shi, M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht500 · Cited by 209
Friberg, L., Skeppholm, M., & Terént, A. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.10.052 · Cited by 207
Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation
Pluymaekers, N. A. H. A., Dudink, E. A. M. P., Luermans, J. G. L. M., Meeder, J. G., Lenderink, T., Widdershoven, J., Bucx, J. J. J., Rienstra, M., Kamp, O., Van Opstal, J. M., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1900353 · Cited by 206
Self-citationvan den Ham, H. A., Klungel, O. H., Singer, D. E., Leufkens, H. G. M., & van Staa, T. P. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.08.033 · Cited by 206
Lopes, R. D., Al-Khatib, S. M., Wallentin, L., Yang, H., Ansell, J., Bahit, M. C., De Caterina, R., Dorian, P., Easton, J. D., Erol, C., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60986-6 · Cited by 206
Desai, N. R., Krumme, A. A., Schneeweiss, S., Shrank, W. H., Brill, G., Pezalla, E. J., Spettell, C. M., Brennan, T. A., Matlin, O. S., Avorn, J., et al. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.05.013 · Cited by 205
Pancholy, S. B., Sharma, P. S., Pancholy, D. S., Patel, T. M., Callans, D. J., & Marchlinski, F. E. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.10.035 · Cited by 204
Metadata
- Authors
- Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M.
- Affiliations
- Birmingham City Hospital (GB)
- Maastricht University Medical Centre (NL)
- Corresponding author
- Lip, Gregory Y.H.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 137
- Issue
- 2
- Pages
- 263-272
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2162586165
- Cited by
- 6,879
- References
- 34
- Citations by year
- 2026: 276 · 2025: 362 · 2024: 419 · 2023: 466 · 2022: 524 · 2021: 590 · 2020: 538 · 2019: 476 · 2018: 507 · 2017: 471 · 2016: 495 · 2015: 474 · 2014: 400 · 2013: 337 · 2012: 304
- FWCI
- 115.14
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- CHEST Journal (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Keywords
- atrial fibrillation, stroke risk stratification, thromboembolism, CHA2DS2-VASc score, CHADS2 score, risk prediction, risk reclassification
- MeSH terms
- Aged, Atrial Fibrillation, Europe, Female, Follow-Up Studies, Humans, Male, Population Surveillance, Prognosis, Retrospective Studies, Risk Factors, Thromboembolism, Reproducibility of Results, Incidence, Risk Assessment, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.